ACIP updated schedules to recommend COVID-19 vaccination for all persons ≥6 months using individual/shared clinical decision-making, prioritizing those at higher risk for severe disease.
The committee requested that CDC standardize and enhance informed-consent materials, including plain-language descriptions of key risks and uncertainties.
Clinicians are encouraged to discuss patient-specific factors (age, prior infection, immunosuppression, CDC-listed comorbidities) and review benefits, risks, and uncertainties before vaccination.
A proposal to require prescriptions for COVID-19 vaccination was not adopted as a barrier to access.